Use of STAT3 dominant-negative (DN) and constitutive active mutants in fibroblast and human prostate tumour cells provided results consistent with the antisense approach and demonstrated that while STAT3 signalling is required it is not sufficient for the migratory and invasiveness phenotype. Here, STAT3 is linked to prostate neoplasm.